Dr. Glabe's research program is focused on amyloid structure and aggregation, in particular beta-amyloid, which is the key pathogenic hallmark of Alzheimer's disease.
To fund research with the highest probability of preventing, slowing, or reversing Alzheimer’s disease through venture-based philanthropy.
Cure Alzheimer’s Fund is registered as a 501(c)(3) public charity under the name, "Alzheimer’s Disease Research Foundation,” and proudly meets all twenty Standards for Charity Accountability.
Cure Alzheimer’s Fund is a “doing business as” name for the Alzheimer’s Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428.
Cure Alzheimer's Fund meets all 20 BBB Charity Standards.
Cure Alzheimer’s Fund is proud to be supported by The Cummings Foundation.